|
ABCF1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.63291602461868E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.97459842815806E-14 |
| Normal-vs-Stage2 |
7.202600E-04 |
| Normal-vs-Stage3 |
7.27007343215291E-12 |
| Normal-vs-Stage4 |
1.65079061531515E-12 |
| Stage1-vs-Stage2 |
6.600600E-03 |
| Stage1-vs-Stage3 |
9.928800E-01 |
| Stage1-vs-Stage4 |
8.076200E-02 |
| Stage2-vs-Stage3 |
1.601720E-02 |
| Stage2-vs-Stage4 |
7.199100E-04 |
| Stage3-vs-Stage4 |
1.003580E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.79567513373058E-13 |
| Normal-vs-AfricanAmerican |
3.92479999999917E-05 |
| Normal-vs-Asian |
9.56550394448641E-11 |
| Caucasian-vs-AfricanAmerican |
2.803200E-01 |
| Caucasian-vs-Asian |
6.681600E-01 |
| AfricanAmerican-vs-Asian |
1.459200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.27393667731712E-12 |
| Normal-vs-Female |
1.63213886850144E-12 |
| Male-vs-Female |
6.439200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.6594282331871E-12 |
| Normal-vs-Age(41-60Yrs) |
1.18793863634892E-13 |
| Normal-vs-Age(61-80Yrs) |
4.10280032170363E-10 |
| Normal-vs-Age(81-100Yrs) |
1.426240E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.993800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.037800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.078400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.123800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.556600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.482600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.339190E-01 |
| Classical-VS-Follicular |
8.366000E-01 |
| Classical-VS-Other |
5.887700E-02 |
| Classical-VS-Normal |
1.72084568816899E-12 |
| Tall-VS-Follicular |
2.269400E-01 |
| Tall-VS-Other |
2.634400E-01 |
| Tall-VS-Normal |
2.93300050913103E-10 |
| Follicular-VS-Other |
1.426000E-01 |
| Follicular-VS-Normal |
7.39139971450697E-10 |
| Other-VS-Normal |
8.27629999977653E-07 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.31750199428416E-11 |
| Normal-vs-N1 |
4.51860771022439E-14 |
| N0-vs-N1 |
9.361900E-04 |
|
|
